PCAT6 and breast cancer: Enhanced PCAT6 expression was further verified in a panel of hypoxic BC cells (Figure S1e, Supporting Information) and doxorubicin‐resistant BC cells (Figure S1f, Supporting Information), with PCAT6 expression levels exhibiting a dependency on doxorubicin dosage (Figure S1g, Supporting Information).